LEXEO THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.38 USD | -7.36% |
|
+0.75% | +29.51% |
| 06-13 | Baird Initiates Lexeo Therapeutics With Outperform Rating, $28 Price Target | MT |
| 06-06 | HC Wainwright Initiates Lexeo Therapeutics at Buy With $22 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LEXEO THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -7.36% | +0.75% | +29.51% | - | - | 573M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LXEO Stock
- Charts Lexeo Therapeutics, Inc.
- Comparison Chart
